BODISEN BIOTECH, INC (CIK: 0001178552) EDGAR, Information, Filings... CompaniesBIO.Com

BODISEN BIOTECH, INC

Mailing address
NORTH PART OF XINQUIA ROAD, YANG LING AG, HIGH-TECH INDUSTRIES DEMONSTRATION ZONE, YANG LING, Delaware, 712100
Phone
86-29-87074957
State location
China
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2870 - (CF Office: Office of Life Sciences) AGRICULTURAL CHEMICALS
Filings
N/A

BODISEN BIOTECH, INC (CIK: 0001178552) is an American company incorporated in the state of China. Head office is located at NORTH PART OF XINQUIA ROAD, YANG LING AG, HIGH-TECH INDUSTRIES DEMONSTRATION ZONE, YANG LING, China, 712100. Work in the industry 2870 - (CF Office: Office of Life Sciences) AGRICULTURAL CHEMICALS. BODISEN BIOTECH, INC is a public company and trade via Over-The-Counter (OTC).

Old names:

STRATABID COM INC from 2002-03-Sep to 2004-14-May

Owner	Filings	Transaction Date	Type of Owner
Wang Lin	0001556181	Aug-08-2012	director, officer: Chief Executive Officer, other: President and Chairman
Yang Chuangjun	0001556182	Aug-08-2012	officer: Chief Operating Officer
Guo Chenglin	0001556183	Aug-08-2012	director
Tong Junyan	0001432692	Jun-04-2007	officer: Chief Financial Officer
McManus Patrick	0001319722	Aug-25-2005	director
Gatton David	0001320181	Aug-25-2005	director
Chen Bo	0001347573	Aug-25-2005	director, 10 percent owner, officer: Executive Director & President
WANG CHUNSHENG	0001357586	Aug-25-2005	officer: Chief Operating Officer
WANG QIONG	0001357587	Aug-25-2005	director, 10 percent owner, officer: Chairman and CEO
WAN WEIRUI	0001357588	Aug-25-2005	director
LAI YILIANG	0001357591	Aug-25-2005	officer: Chief Financial Officer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by BODISEN BIOTECH, INC

Filings	Format	Description	Filed/Effective	File/Film Number
REVOKED	Document	Acc-no: 9999999997-16-025275 (34 Act) Size: KB	Aug-26-2016	000-54780 161853036
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001013762-13-001218 (34 Act) Size: KB	Sep-11-2013	001-32616 131090349
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001013762-13-001089 (34 Act) Size: KB	Aug-15-2013	001-32616 131040007
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001013762-13-000542 (34 Act) Size: KB	Apr-16-2013	001-32616 13762876
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001013762-13-000463 (34 Act) Size: KB	Apr-01-2013	001-32616 13730336
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001013762-12-002168 (34 Act) Size: KB	Nov-19-2012	001-32616 121213572
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001013762-12-002105 (34 Act) Size: KB	Nov-14-2012	001-32616 121202638
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001013762-12-001749 (34 Act) Size: KB	Aug-30-2012	001-32616 121064771
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001013762-12-001677 (34 Act) Size: KB	Aug-20-2012	001-32616 121044565
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001357587-12-000002 ( Act) Size: 0 KB	Aug-17-2012
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001347573-12-000002 ( Act) Size: 0 KB	Aug-17-2012
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001556181-12-000001 ( Act) Size: 0 KB	Aug-17-2012
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001556182-12-000001 ( Act) Size: 0 KB	Aug-17-2012
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001556183-12-000001 ( Act) Size: 0 KB	Aug-17-2012
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001013762-12-001599 (34 Act) Size: KB	Aug-14-2012	001-32616 121031076
8-A12G	Document	Form for registration of a class of securities pursuant to section 12(g) Acc-no: 0001013762-12-001552 (34 Act) Size: KB	Aug-09-2012	000-54780 121017887
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001510700-12-000005 (34 Act) Size: KB	Jun-29-2012	005-78730 12934774
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001510700-12-000004 (34 Act) Size: KB	May-29-2012	005-78730 12872795
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001013762-12-001180 (34 Act) Size: KB	May-18-2012	001-32616 12854322
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001013762-12-001147 (34 Act) Size: KB	May-16-2012	001-32616 12847072

Recent 20 filings. View all BODISEN BIOTECH, INC filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Where is BODISEN BIOTECH, INC's headquarters?

BODISEN BIOTECH, INC is located in NORTH PART OF XINQUIA ROAD, YANG LING AG, HIGH-TECH INDUSTRIES DEMONSTRATION ZONE, YANG LING, China, 712100.

What is the BODISEN BIOTECH, INC's website?

BODISEN BIOTECH, INC's website is unknown

Who invested in BODISEN BIOTECH, INC?

Updating!

How much funding has BODISEN BIOTECH, INC raised to date?

Updating!

When was the last funding round for BODISEN BIOTECH, INC?

Updating!

When was BODISEN BIOTECH, INC founded?

Updating!

BODISEN BIOTECH, INC overview
BODISEN BIOTECH, INC job
BODISEN BIOTECH, INC stock
BODISEN BIOTECH, INC ownership
BODISEN BIOTECH, INC CEO
BODISEN BIOTECH, INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.